Details for New Drug Application (NDA): 020838

✉ Email this page to a colleague

NDA 020838 describes ATACAND, which is a drug marketed by Ani Pharms and is included in two NDAs. It is available from five suppliers. Additional details are available on the ATACAND profile page.

The generic ingredient in ATACAND is candesartan cilexetil; hydrochlorothiazide. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the candesartan cilexetil; hydrochlorothiazide profile page.

Summary for 020838

Tradename:	ATACAND
Applicant:	Ani Pharms
Ingredient:	candesartan cilexetil
Patents:	0

Pharmacology for NDA: 020838

Mechanism of Action	Angiotensin 2 Receptor Antagonists

Suppliers and Packaging for NDA: 020838

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ATACAND	candesartan cilexetil	TABLET;ORAL	020838	NDA AUTHORIZED GENERIC	Par Pharmaceutical Inc.	49884-658	49884-658-09	90 TABLET in 1 BOTTLE (49884-658-09)
ATACAND	candesartan cilexetil	TABLET;ORAL	020838	NDA AUTHORIZED GENERIC	Par Pharmaceutical Inc.	49884-659	49884-659-09	90 TABLET in 1 BOTTLE (49884-659-09)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	4MG
Approval Date:	Jun 4, 1998	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	8MG
Approval Date:	Jun 4, 1998	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	16MG
Approval Date:	Jun 4, 1998	TE:	AB	RLD:	Yes

Expired US Patents for NDA 020838

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ani Pharms	ATACAND	candesartan cilexetil	TABLET;ORAL	020838-003	Jun 4, 1998	⤷ Sign Up	⤷ Sign Up
Ani Pharms	ATACAND	candesartan cilexetil	TABLET;ORAL	020838-003	Jun 4, 1998	⤷ Sign Up	⤷ Sign Up
Ani Pharms	ATACAND	candesartan cilexetil	TABLET;ORAL	020838-002	Jun 4, 1998	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.